The Amyloidosis Channel is supported through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ISA 2022 | Improving diagnosis in AL amyloidosis using surrogate organ tissues for biopsies

Name: Improving diagnosis in AL amyloidosis using surrogate organ tissues for biopsies
Uploaded: 2022-09-06T00:00:00Z
Duration: 1 min 58 s
Description: Despina Fotiou, MD, PhD, University of Athens, Athens, Greece, discusses the benefit of using surrogate organ tissues for biopsies to diagnose patients with AL amyloidosis, and further explains how this method reduces the complications associated with using target organs for biopsies. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Despina Fotiou • 6 Sep 2022

ISA 2022

Amyloidosis Rare Diseases

Despina Fotiou, MD, PhD, University of Athens, Athens, Greece, discusses the benefit of using surrogate organ tissues for biopsies to diagnose patients with AL amyloidosis, and further explains how this method reduces the complications associated with using target organs for biopsies. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.